Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | AMGN | GILD | BIIB | CELG |
| Company | Pdl Biopharma Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.73 | 333.93 | 83.37 | 198.13 | 108.01 |
| High | 2.78 | 339.00 | 84.52 | 199.78 | 108.59 |
| Low | 2.39 | 331.00 | 82.76 | 196.81 | 107.27 |
| Last | 2.47 | 334.37 | 84.14 | 198.82 | 108.24 |
| Change | -0.23 | +1.57 | +1.09 | +0.61 | +0.11 |
| % Change | -8.52% | +0.47% | +1.31% | +0.31% | +0.10% |
| Volume | 30,270,700 | 747,708 | 5,925,760 | 357,081 | 191,230,496 |
| 20-Day Average Volume | 4,709,610 | 1,702,390 | 6,242,152 | 784,901 | 16,188,930 |
| Previous Close | 2.70 | 332.80 | 83.05 | 198.21 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 329.45 | 79.66 | 201.93 | 108.17 |
| 20-Day Raw Stochastic | 17.78% | 90.82% | 95.34% | 47.26% | 63.25% |
| 20-Day Relative Strength | 46.04% | 58.23% | 72.80% | 42.12% | 64.69% |
| Weighted Alpha | -24.80 | +27.59 | +19.25 | -22.66 | +46.30 |
| Today's Opinion | 64% Sell | 96% Buy | 88% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 88% Buy | 88% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 56% Sell | 72% Buy | 40% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | +2.10% since 09/11/24 | +4.30% since 09/11/24 | +0.21% since 09/11/24 | -1.97% since 11/13/19 |
| Low | 2.39 on 12/30/20 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 192.25 on 09/13/24 | 107.27 on 11/20/19 |
| High | 2.84 on 12/29/20 | 338.72 on 09/18/24 | 84.89 on 09/12/24 | 202.79 on 09/17/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | +4.81% since 08/16/24 | +14.42% since 08/16/24 | -1.19% since 08/16/24 | +5.14% since 10/18/19 |
| Low | 2.39 on 12/30/20 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
| High | 2.84 on 12/29/20 | 338.72 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | +10.10% since 06/18/24 | +33.68% since 06/18/24 | -10.80% since 06/18/24 | +13.63% since 08/20/19 |
| Low | 2.09 on 11/02/20 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
| High | 3.24 on 10/01/20 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | +24.37% since 03/18/24 | +15.23% since 03/18/24 | -9.07% since 03/18/24 | +14.14% since 05/20/19 |
| Low | 2.09 on 11/02/20 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 3.78 on 08/19/20 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 178,525,568 | 103,468,096 | 28,858,782 | 77,035,920 |
| Shares Outstanding, K | 114,227 | 536,435 | 1,245,853 | 145,597 | 711,714 |
| Annual Sales | 54,760,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -70,410,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 4,120,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
| Last Quarter Net Income | 4,400,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
| 60-Month Beta | 1.11 | 0.61 | 0.18 | -0.06 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 12/31/21 | 10/29/24 | 11/05/24 | 08/01/24 | 10/31/19 |
| Most Recent Dividend | 0.050 on 06/02/16 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | 09/21/20 | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 17.69 | 12.27 | 10.99 |